MGTA insider filings

Magenta Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-02-09. Screen MGTA transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for MGTA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Magenta Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2023-02-094Third Rock Ventures IV, L.P. — 10% owner
Third Rock Ventures GP IV, L.P. — 10% owner
TRV GP IV, LLC — 10% owner
Sale (S): 2,200,000 @ $0.83 · Sale (S): 1,500,000 @ $0.82EDGAR
2022-12-024Beetham Thomas W. — See RemarksGrant/award (A): 3,000 @ $0.94EDGAR
2022-12-024Mahoney Stephen F. — See RemarksGrant/award (A): 3,000 @ $0.94EDGAR
2022-12-024Deardorf Caren — Chief Commercial OfficerGrant/award (A): 3,000 @ $0.94EDGAR
2022-12-024GARDNER JASON — See Remarks, DirectorGrant/award (A): 3,000 @ $0.94EDGAR
2022-12-024Stants Kristen — Chief People OfficerGrant/award (A): 3,000 @ $0.94EDGAR
2022-08-174VASCONCELLES MICHAEL — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2022-08-014Olson Lisa — See RemarksGrant/award (A): 100,000 (derivative) @ $0EDGAR
2022-08-014Beetham Thomas W. — See RemarksGrant/award (A): 75,000 (derivative) @ $0EDGAR
2022-08-014Humphrey Jeffrey — Chief Medical OfficerGrant/award (A): 75,000 (derivative) @ $0EDGAR
2022-08-014GARDNER JASON — See Remarks, DirectorGrant/award (A): 187,500 (derivative) @ $0EDGAR
2022-08-014Nichols David Wayne — Chief Technical OfficerGrant/award (A): 75,000 (derivative) @ $0EDGAR
2022-08-014Mahoney Stephen F. — See RemarksGrant/award (A): 130,000 (derivative) @ $0EDGAR
2022-08-014Stants Kristen — Chief People OfficerGrant/award (A): 85,000 (derivative) @ $0EDGAR
2022-08-014Deardorf Caren — Chief Commercial OfficerGrant/award (A): 75,000 (derivative) @ $0EDGAR
2022-06-304Scadden David — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-304McGeorge Anne — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-304Albers Jeffrey W. — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-304Lawton Alison Frances — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-304Daniel Thomas O — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-304Booth Bruce — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-304RONNEBERG AMY L — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-064Stants Kristen — Chief People OfficerGrant/award (A): 3,000 @ $0.99EDGAR
2022-06-064Deardorf Caren — Chief Commercial OfficerGrant/award (A): 3,000 @ $0.99EDGAR
2022-06-064GARDNER JASON — See Remarks, DirectorGrant/award (A): 3,000 @ $0.99EDGAR
2022-06-064Beetham Thomas W. — See RemarksGrant/award (A): 3,000 @ $0.99EDGAR
2022-05-194Olson Lisa — See RemarksGrant/award (A): 50,000 (derivative) @ $0EDGAR
2022-05-194Humphrey Jeffrey — Chief Medical OfficerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2022-05-194GARDNER JASON — See Remarks, DirectorGrant/award (A): 162,500 (derivative) @ $0EDGAR
2022-05-194Stants Kristen — Chief People OfficerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2022-05-194Nichols David Wayne — Chief Technical OfficerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2022-05-194Mahoney Stephen F. — See RemarksGrant/award (A): 62,500 (derivative) @ $0EDGAR
2022-05-194Beetham Thomas W. — See RemarksGrant/award (A): 50,000 (derivative) @ $0EDGAR
2022-05-194Deardorf Caren — Chief Commercial OfficerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2022-02-174GARDNER JASON — See Remarks, DirectorGrant/award (A): 187,500 (derivative) @ $0EDGAR
2022-02-174Humphrey Jeffrey — Chief Medical OfficerGrant/award (A): 75,000 (derivative) @ $0EDGAR
2022-02-174Deardorf Caren — Chief Commercial OfficerGrant/award (A): 75,000 (derivative) @ $0EDGAR
2022-02-174Stants Kristen — Chief People OfficerGrant/award (A): 85,000 (derivative) @ $0EDGAR
2022-02-174Nichols David Wayne — Chief Technical OfficerGrant/award (A): 75,000 (derivative) @ $0EDGAR
2022-02-174Olson Lisa — See RemarksGrant/award (A): 100,000 (derivative) @ $0EDGAR
2022-02-174Mahoney Stephen F. — See RemarksGrant/award (A): 130,000 (derivative) @ $0EDGAR
2022-02-174Beetham Thomas W. — See RemarksGrant/award (A): 75,000 (derivative) @ $0EDGAR
2021-10-044Humphrey Jeffrey — Chief Medical OfficerGrant/award (A): 275,000 (derivative) @ $0EDGAR
2021-09-234Borisy Alexis — DirectorOther (J): 4,100 @ $0EDGAR
2021-09-204Mahoney Stephen F. — See RemarksSale (S): 5,736 @ $6.73EDGAR
2021-09-204Deardorf Caren — Chief Commercial OfficerSale (S): 6,238 @ $6.73EDGAR
2021-09-204GARDNER JASON — See RemarksSale (S): 14,340 @ $6.73EDGAR
2021-09-204Beetham Thomas W. — See RemarksSale (S): 6,103 @ $6.73EDGAR
2021-09-204Olson Lisa — See RemarksSale (S): 5,736 @ $6.73EDGAR
2021-09-204Nichols David Wayne — Chief Technical OfficerSale (S): 5,694 @ $6.73EDGAR

Recent 8-K events — Magenta Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-128-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-228-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-268-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-128-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-098-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
8.01 — Other Events
EDGAR
2026-01-128-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=MGTA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs